Literature DB >> 11167639

Postoperative mortality in patients with liver cirrhosis undergoing transurethral resection of the prostate: a Danish nationwide cohort study.

S S Nielsen1, A M Thulstrup, L Lund, H Vilstrup, H T Sørensen.   

Abstract

OBJECTIVE: To examine the risk of 30-day postoperative mortality from transurethral resection of the prostate (TURP) in patients with liver cirrhosis, who are reportedly at considerably increased perioperative risk. PATIENTS AND METHODS: For the period 1 January 1977 to 31 December 1993, a population-based cohort was identified comprising Danish patients diagnosed with liver cirrhosis and a random sample of Danes also undergoing TURP. Logistic regression models were used to estimate the association between liver cirrhosis, age, type of admission, comorbidity and 30-day mortality.
RESULTS: In a cohort of 23 133 patients with liver cirrhosis, 30 underwent TURP; 150 controls with no liver cirrhosis also underwent the same procedure. Of the patients with liver cirrhosis, 6.7% died within 30 days of TURP; the estimated adjusted odds ratio was 3.0 (95% confidence interval 0.4-22.9) for the 30-day postoperative mortality in patients with liver cirrhosis compared with patients without (mortality 2%). Advanced age, comorbidity and acute admission seemed to be associated with an increased postoperative mortality.
CONCLUSION: This study indicates that TURP in patients with liver cirrhosis was associated with increased mortality.

Entities:  

Mesh:

Year:  2001        PMID: 11167639     DOI: 10.1046/j.1464-410x.2001.02048.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  5 in total

1.  Perioperative risk factors in patients with liver disease undergoing non-hepatic surgery.

Authors:  Chandra Kant Pandey; Sunaina Tejpal Karna; Vijay Kant Pandey; Manish Tandon; Amit Singhal; Vivek Mangla
Journal:  World J Gastrointest Surg       Date:  2012-12-27

2.  Safety and efficacy of tubeless percutaneous nephrolithotomy in patients on anti-platelet therapy and cirrhotic patients.

Authors:  Yeong-Chin Jou; Cheng-Huang Shen; Chang-Te Lin; Ming-Chin Cheng; Pi-Che Chen; Yuh-Shyan Tsai
Journal:  Urol Res       Date:  2011-02-05

Review 3.  Outcomes of patients with cirrhosis undergoing non-hepatic surgery: risk assessment and management.

Authors:  Farida Millwala; Geoffrey C Nguyen; Paul J Thuluvath
Journal:  World J Gastroenterol       Date:  2007-08-14       Impact factor: 5.742

Review 4.  Procedure-related bleeding risk in patients with cirrhosis and severe thrombocytopenia.

Authors:  Domenico Alvaro; Nicola Caporaso; Edoardo Giovanni Giannini; Angelo Iacobellis; Mariacristina Morelli; Pierluigi Toniutto; Francesco Violi
Journal:  Eur J Clin Invest       Date:  2021-02-26       Impact factor: 4.686

5.  Cirrhosis patients have increased risk of complications after hip or knee arthroplasty.

Authors:  Thomas Deleuran; Hendrik Vilstrup; Søren Overgaard; Peter Jepsen
Journal:  Acta Orthop       Date:  2014-09-19       Impact factor: 3.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.